RecruitingNot ApplicableNCT04643106

Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function

A Multi-center, Randomized, Investigator-initiated Trial to Evaluate the Efficacy of PRreservation of ovArian Function, Hemostasis, and sAfety of a Hemostatic Agent Versus Suturing During Laparoscopic Ovarian Cystectomy for Endometrioma


Sponsor

Seoul National University Hospital

Enrollment

90 participants

Start Date

Feb 25, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate the efficacy of preservation of ovarian function, hemostasis, and safety of a hemostatic agent versus suturing during laparoscopic ovarian cystectomy for ovarian endometriosis.


Eligibility

Sex: FEMALEMin Age: 19 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Hemostatic agent (EVICEL®) application during laparoscopic ovarian cystectomy and a procedure called suturing with barbed sutures during laparoscopic ovarian cystectomy for people with benign ovarian cyst. The study is currently recruiting participants at 2 locations. People eligible for this study include women aged 19 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREHemostatic agent (EVICEL®) application during laparoscopic ovarian cystectomy

During laparoscopic ovarian cystectomy, bleeding will be controlled by using a hemostatic agent (EVICEL®)

PROCEDUREsuturing with barbed sutures during laparoscopic ovarian cystectomy

During laparoscopic ovarian cystectomy, suturing of ovarian inner surface will be conducted to stop bleeding


Locations(2)

Dongguk University Ilsan Hospital

Goyang-si, Gyeonggi-do, South Korea

Seoul National University Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04643106


Related Trials